PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 17 filers reported holding PROTEON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,000 | – | 24,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $482,000 | 15.66% |
| Pharmstandard International S.A. | 1,165,344 | $1,777,000 | 6.16% |
| Abingworth LLP | 2,017,872 | $3,027,000 | 2.41% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,505,000 | 0.65% |
| RA Capital Management | 1,337,462 | $2,040,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,224,899 | $1,868,000 | 0.10% |
| Perceptive Advisors | 334,116 | $518,000 | 0.03% |
| WEDBUSH SECURITIES INC | 53,439 | $81,000 | 0.01% |
| Baker Brothers Advisors | 298,591 | $455,000 | 0.00% |
| FINANCIAL COUNSELORS INC | 50,000 | $78,000 | 0.00% |